Explore Public Citizen's Access to Medicines Program
 | The U.S. Trade Representative is pressuring developing countries to trade away access to medicines in the proposed Trans-Pacific Partnership Agreement (TPP). Public Citizen is working for a better partnership. | |  | On November 10, public health groups in a dozen countries launched a global campaign to challenge Abbott Laboratories' monopolistic hold on Kaletra (lopinavir + ritonavir), a critical HIV/AIDS medicine. |
 |  |
For more information on our work, contact us at medsaccess@citizen.org
Follow Public Citizen's Global Access to Medicines Program on Twitter: @PCMedsAccess